semaglutide glp-1 injections | for Weight Loss How GLP-1 medications are transforming

In some clinical trials, semaglutide has been found to lead to significant weight loss in people with obesity

Overpatented, overpriced: How Humiras 132 patents blocked competition and cost Americans billions

4 Clinical Research, Ardelyx, Inc., Waltham, MA, USA

2018 Aug;20(8):1951-1956

The STEP trials demonstrated that semaglutide produces weight loss averaging 1522% over 68 weeks, while the SURMOUNT trials showed tirzepatide achieves 2022% weight reduction

If your insurance plan does not cover Zepbound or the cost is a concern, your healthcare provider may be able to suggest alternative weight-loss medications that are covered by your insurance plan